1. Home
  2. FLS vs LEGN Comparison

FLS vs LEGN Comparison

Compare FLS & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$70.95

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$21.90

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
LEGN
Founded
1790
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FLS
LEGN
Price
$70.95
$21.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
13
Target Price
$76.40
$69.58
AVG Volume (30 Days)
1.4M
2.6M
Earning Date
10-28-2025
11-12-2025
Dividend Yield
1.18%
N/A
EPS Growth
69.42
N/A
EPS
3.44
N/A
Revenue
$4,687,417,000.00
$909,045,000.00
Revenue This Year
$5.80
$68.83
Revenue Next Year
$4.04
$51.27
P/E Ratio
$20.66
N/A
Revenue Growth
3.19
74.75
52 Week Low
$37.34
$21.19
52 Week High
$74.63
$45.30

Technical Indicators

Market Signals
Indicator
FLS
LEGN
Relative Strength Index (RSI) 55.92 25.47
Support Level $68.91 $21.19
Resistance Level $74.63 $28.97
Average True Range (ATR) 1.87 1.27
MACD -0.60 -0.26
Stochastic Oscillator 35.67 9.13

Price Performance

Historical Comparison
FLS
LEGN

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: